Akut Lösemili Hastalarda Anjiogenezisin Değerlendirilmesi

Cilt: 29 Sayı: 2 1 Haziran 2003
  • Tülay Özçelik
  • Rıdvan Ali
  • Fahir Özkalemkaş
  • Vildan Özkocaman
  • Ülkü Ozan
  • Hülya Öztürk
  • Ahmet Tunalı
PDF İndir
EN TR

Evaluation of Angiogenesis in Acute Leukemia Patients

Öz

The importance of angiogenesis for solid tumors is well established. In contrast only few data are available for hematologic neoplasms. In our study we aimed to investigate the role of angiogenesis in bone marrow biopsies of untreated acute leukemia patients. Microvessel counts in the bone marrow biopsies of untreated patients were compared with normal controls and with ones counted at the time of complete remission. Thirteen patients were included in the study. Bone marrow samples were immunohistochemically stained with von Willebrand factor. Microvessels were scored in two areas of the highest microvessel density in sections of each bone marrow specimen. Angiogenesis was expressed as the number of vessels counted at x400 magnification. Bone marrow microvessel count was significantly increased in acute leukemia patients compared with controls (p<0,01). Additionally microvessel count at presentation was significantly higher than the one assassed at the time of complete remission (p<0,01). In conclusion by demonstrating increased angiogenesis in the bone marrow of acute leukemia patients we think that angiogenesis may play a role in the pathophysiology of acute leukemia.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Tülay Özçelik Bu kişi benim

Rıdvan Ali Bu kişi benim

Fahir Özkalemkaş Bu kişi benim

Vildan Özkocaman Bu kişi benim

Ülkü Ozan Bu kişi benim

Hülya Öztürk Bu kişi benim

Ahmet Tunalı Bu kişi benim

Yayımlanma Tarihi

1 Haziran 2003

Gönderilme Tarihi

1 Haziran 2003

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2003 Cilt: 29 Sayı: 2

Kaynak Göster

APA
Özçelik, T., Ali, R., Özkalemkaş, F., Özkocaman, V., Ozan, Ü., Öztürk, H., & Tunalı, A. (2003). Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty, 29(2), 1-6. https://izlik.org/JA26UB53UY
AMA
1.Özçelik T, Ali R, Özkalemkaş F, vd. Evaluation of Angiogenesis in Acute Leukemia Patients. Uludağ Tıp Derg. 2003;29(2):1-6. https://izlik.org/JA26UB53UY
Chicago
Özçelik, Tülay, Rıdvan Ali, Fahir Özkalemkaş, vd. 2003. “Evaluation of Angiogenesis in Acute Leukemia Patients”. Journal of Uludağ University Medical Faculty 29 (2): 1-6. https://izlik.org/JA26UB53UY.
EndNote
Özçelik T, Ali R, Özkalemkaş F, Özkocaman V, Ozan Ü, Öztürk H, Tunalı A (01 Haziran 2003) Evaluation of Angiogenesis in Acute Leukemia Patients. Journal of Uludağ University Medical Faculty 29 2 1–6.
IEEE
[1]T. Özçelik vd., “Evaluation of Angiogenesis in Acute Leukemia Patients”, Uludağ Tıp Derg, c. 29, sy 2, ss. 1–6, Haz. 2003, [çevrimiçi]. Erişim adresi: https://izlik.org/JA26UB53UY
ISNAD
Özçelik, Tülay - Ali, Rıdvan - Özkalemkaş, Fahir - Özkocaman, Vildan - Ozan, Ülkü - Öztürk, Hülya - Tunalı, Ahmet. “Evaluation of Angiogenesis in Acute Leukemia Patients”. Journal of Uludağ University Medical Faculty 29/2 (01 Haziran 2003): 1-6. https://izlik.org/JA26UB53UY.
JAMA
1.Özçelik T, Ali R, Özkalemkaş F, Özkocaman V, Ozan Ü, Öztürk H, Tunalı A. Evaluation of Angiogenesis in Acute Leukemia Patients. Uludağ Tıp Derg. 2003;29:1–6.
MLA
Özçelik, Tülay, vd. “Evaluation of Angiogenesis in Acute Leukemia Patients”. Journal of Uludağ University Medical Faculty, c. 29, sy 2, Haziran 2003, ss. 1-6, https://izlik.org/JA26UB53UY.
Vancouver
1.Tülay Özçelik, Rıdvan Ali, Fahir Özkalemkaş, Vildan Özkocaman, Ülkü Ozan, Hülya Öztürk, Ahmet Tunalı. Evaluation of Angiogenesis in Acute Leukemia Patients. Uludağ Tıp Derg [Internet]. 01 Haziran 2003;29(2):1-6. Erişim adresi: https://izlik.org/JA26UB53UY

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023